Our results demonstrate that systemic post-injury treatment with GM-CSF is associated with improved host defense in our juvenile rat TBI/H model as evidenced by reduced bacterial load following pneumonia challenge; increased percentage of blood monocytes expressing elevated levels of MHC II molecules; and preservation of splenic lymphocytes. Here, CSF2 is linked to pneumonia.